/ASAP.ST
ASAP.ST Stock - Asarina Pharma AB (publ)
Healthcare|BiotechnologySTO
$0.03-31.03%
$0.01 (-31.03%) • Oct 1
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.03
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ASAP.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.03 – $0.03
TARGET (TP)$0.03
STOP LOSS$0.03
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.17
52W High$1.31
52W Low$0.03
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-423,000 | $-406,000 | $-388,000 | $-89,000 | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-14,640,000 | $-14,687,000 | $-38,284,000 | $-81,406,000 | $-81,034,000 |
| Net Income | $-12,828,000 | $-13,283,000 | $-31,658,000 | $-75,256,000 | $-71,076,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.57 | $-0.71 | $-1.69 | $-4.02 | $-4.30 |
Company Overview
Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ASAP.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.07
Q1 2024
EPS Surprise History
Q1 22
No data
Q2 22
No data
Q1 23
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q1 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 13, 2025 | — | — | — | — |
Q1 2025 | Feb 25, 2025 | — | — | — | — |
Q3 2024 | Sep 25, 2024 | — | — | — | — |
Q2 2024 | Jun 15, 2024 | — | — | — | — |
Q1 2024 | Feb 27, 2024 | — | $-0.07 | — | — |
Q1 2024 | Feb 23, 2024 | — | $-0.07 | — | — |
Q3 2023 | Aug 23, 2023 | — | $-0.21 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.21 | — | — |
Q1 2023 | Feb 27, 2023 | — | $-0.14 | — | — |
Q1 2023 | Feb 1, 2023 | — | $-0.14 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.22 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.21 | — | — |
Q1 2022 | Feb 24, 2022 | — | $-0.05 | — | — |
Q4 2021 | Nov 25, 2021 | — | $-0.40 | — | — |
Q3 2021 | Aug 19, 2021 | — | $-0.81 | — | — |
Q2 2021 | May 18, 2021 | — | $-0.32 | — | — |
Q1 2021 | Feb 25, 2021 | — | $-0.95 | — | — |
Q4 2020 | Nov 25, 2020 | — | $-0.90 | — | — |
Q3 2020 | Aug 19, 2020 | — | $-1.05 | — | — |
Q2 2020 | May 27, 2020 | — | $-0.94 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ASAP.ST
What is ASAP.ST's current stock price?
Asarina Pharma AB (publ) (ASAP.ST) is currently trading at $0.03 per share. The stock has moved -31.03% today.
What is the analyst price target for ASAP.ST?
No analyst price targets are currently available for this stock.
What sector is Asarina Pharma AB (publ) in?
Asarina Pharma AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is ASAP.ST's market cap?
Asarina Pharma AB (publ) has a market capitalization of $0.00 billion, making it a small-cap company.
Does ASAP.ST pay dividends?
No, Asarina Pharma AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACE.ST
Ascelia Pharma AB (publ)
$3.17
Mkt Cap: $0.4B
BIOA-B.ST
BioArctic AB (publ)
$320.20
Mkt Cap: $28.4B
BIOVIC-B.ST
Biovica International AB (publ)
$0.34
Mkt Cap: $0.1B
CANTA.ST
Cantargia AB (publ)
$4.09
Mkt Cap: $1.0B
SPRINT.ST
Sprint Bioscience AB (publ)
$1.45
Mkt Cap: $0.2B
Explore stocks similar to ASAP.ST for comparison